{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T15:32:16Z","timestamp":1773847936441,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.clcc.2023.09.001","type":"journal-article","created":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T04:57:46Z","timestamp":1694235466000},"page":"402-410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Stereotactic Body Radiotherapy for Management of Pulmonary Oligometastases in Stage IV Colorectal Cancer: A Perspective"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3108-7917","authenticated-orcid":false,"given":"Michael X.","family":"Fu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catarina","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bella","family":"Milan-Chhatrisha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishita","family":"Gadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2023.09.001_bib0001","unstructured":"Rodriguez-Bigas MA, Lin EH, Crane CH. Stage IV Colorectal Cancer. 2003. Accessed January 10, 2022. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK13267\/."},{"issue":"1","key":"10.1016\/j.clcc.2023.09.001_bib0002","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.clcc.2023.09.001_bib0003","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/annonc\/mdi246","article-title":"Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates","volume":"16","author":"Folprecht","year":"2005","journal-title":"Ann Oncol"},{"issue":"41","key":"10.1016\/j.clcc.2023.09.001_bib0004","doi-asserted-by":"crossref","first-page":"11767","DOI":"10.3748\/wjg.v21.i41.11767","article-title":"Colorectal cancer: Metastases to a single organ","volume":"21","author":"Vatandoust","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.clcc.2023.09.001_bib0005","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","article-title":"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer","volume":"27","author":"van Cutsem","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2023.09.001_bib0006","unstructured":"NICE Recommendations | Colorectal cancer | Guidance. Accessed January 10, 2022. https:\/\/www.nice.org.uk\/guidance\/ng151\/chapter\/Recommendations."},{"key":"10.1016\/j.clcc.2023.09.001_bib0007","doi-asserted-by":"crossref","DOI":"10.1177\/1533033818794936","article-title":"Stereotactic radiotherapy for pulmonary oligometastases from colorectal cancer: a systematic review and meta-analysis","volume":"17","author":"Jingu","year":"2018","journal-title":"Technol Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.clcc.2023.09.001_bib0008","first-page":"1188","article-title":"Tumor Control and overall survival after stereotactic body radiotherapy for pulmonary oligometastases from colorectal cancer: a meta-analysis","volume":"52","author":"Choi","year":"2020","journal-title":"Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.clcc.2023.09.001_bib0009","doi-asserted-by":"crossref","first-page":"5988","DOI":"10.21037\/apm-20-919","article-title":"The multidisciplinary management of oligometastases from colorectal cancer: a narrative review","volume":"10","author":"Chandy","year":"2021","journal-title":"Ann Palliat Med"},{"issue":"8","key":"10.1016\/j.clcc.2023.09.001_bib0010","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: the report of AAPM Task Group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"issue":"1","key":"10.1016\/j.clcc.2023.09.001_bib0011","first-page":"58","article-title":"Lung metastases treated with stereotactic ablative radiation therapy in oligometastatic colorectal cancer patients: outcomes and prognostic factors after long-term follow-up","volume":"16","author":"Agolli","year":"2017","journal-title":"Clin Colorectal Cancer"},{"issue":"2","key":"10.1016\/j.clcc.2023.09.001_bib0012","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/jso.23058","article-title":"High dose stereotactic body radiotherapy using three fractions for colorectal oligometastases","volume":"106","author":"Bae","year":"2012","journal-title":"J Surg Oncol"},{"issue":"5","key":"10.1016\/j.clcc.2023.09.001_bib0013","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.ijrobp.2015.04.004","article-title":"Colorectal histology is associated with an increased risk of local failure in lung metastases treated with stereotactic ablative radiation therapy","volume":"92","author":"Binkley","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.clcc.2023.09.001_bib0014","first-page":"158","article-title":"Stereotactic body radiotherapy for colorectal lung oligometastases: preliminary single-institution results","volume":"20","author":"Carvajal","year":"2015","journal-title":"J BUON"},{"issue":"4","key":"10.1016\/j.clcc.2023.09.001_bib0015","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10585-019-09976-z","article-title":"Stereotactic radiation therapy in oligometastatic colorectal cancer: outcome of 102 patients and 150 lesions","volume":"36","author":"Dell'Acqua","year":"2019","journal-title":"Clin Exp Metastasis"},{"issue":"8","key":"10.1016\/j.clcc.2023.09.001_bib0016","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.clon.2016.02.001","article-title":"Exploratory Analysis on overall survival after either surgery or stereotactic radiotherapy for lung oligometastases from colorectal cancer","volume":"28","author":"Filippi","year":"2016","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"7","key":"10.1016\/j.clcc.2023.09.001_bib0017","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00432-017-2373-y","article-title":"Role of stereotactic body radiation therapy for lung metastases from radio-resistant primary tumours","volume":"143","author":"Franceschini","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"10.1016\/j.clcc.2023.09.001_bib0018","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.21873\/anticanres.11621","article-title":"Dose escalation improves outcome in stereotactic body radiotherapy for pulmonary oligometastases from colorectal cancer","volume":"37","author":"Jingu","year":"2017","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.clcc.2023.09.001_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-015-0546-x","article-title":"Clinical efficacy of stereotactic ablative radiotherapy for lung metastases arising from colorectal cancer","volume":"10","author":"Jung","year":"2015","journal-title":"Radiation Oncol"},{"issue":"3","key":"10.1016\/j.clcc.2023.09.001_bib0020","first-page":"e211","article-title":"Radiosensitivity of colon and rectal lung oligometastasis treated with stereotactic ablative radiotherapy","volume":"16","author":"Kinj","year":"2017","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.clcc.2023.09.001_bib0021","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3389\/fonc.2019.01080","article-title":"Prognostic factors and optimal response interval for stereotactic body radiotherapy in patients with lung oligometastases or oligoprogression from colorectal cancer","volume":"9","author":"Li","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.clcc.2023.09.001_bib0022","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.radonc.2021.10.023","article-title":"A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study","volume":"166","author":"Nicosia","year":"2022","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.clcc.2023.09.001_bib0023","doi-asserted-by":"crossref","first-page":"315","DOI":"10.21873\/anticanres.11323","article-title":"Stereotactic body radiotherapy in patients with lung oligometastases from colorectal cancer","volume":"37","author":"Pasqualetti","year":"2017","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.clcc.2023.09.001_bib0024","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/COC.0000000000000220","article-title":"Stereotactic body radiotherapy for lung metastases from colorectal cancer: prognostic factors for disease control and survival","volume":"41","author":"Qiu","year":"2018","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clcc.2023.09.001_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-017-0773-4","article-title":"Lung metastases treated with stereotactic body radiotherapy: the RSSearch\u00ae patient Registry's experience","volume":"12","author":"Ricco","year":"2017","journal-title":"Radiation Oncol"},{"key":"10.1016\/j.clcc.2023.09.001_bib0026","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.radonc.2019.10.004","article-title":"Prognostic factors for local control and survival for inoperable pulmonary colorectal oligometastases treated with stereotactic body radiotherapy","volume":"144","author":"Sharma","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clcc.2023.09.001_bib0027","doi-asserted-by":"crossref","unstructured":"Wegner RE, Ahmed N, Hasan S, McCormick J, Kirichenko A v, Colonias A. Stereotactic body radiotherapy for lung metastases from colorectal cancer: a single institution experience. https:\/\/doi.org\/102217\/crc-2018-0005. 2018;7(3):CRC05. doi:10.2217\/CRC-2018-0005.","DOI":"10.2217\/crc-2018-0005"},{"issue":"1","key":"10.1016\/j.clcc.2023.09.001_bib0028","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jtho.2019.08.2505","article-title":"Biologically effective dose in stereotactic body radiotherapy and survival for patients with early-stage NSCLC","volume":"15","author":"Moreno","year":"2020","journal-title":"J Thorac Oncol"},{"issue":"2","key":"10.1016\/j.clcc.2023.09.001_bib0029","first-page":"139","article-title":"Prescription to 50-75% isodose line may be optimum for linear accelerator based radiosurgery of cranial lesions","volume":"3","author":"Zhao","year":"2014","journal-title":"J Radiosurg SBRT"},{"issue":"2","key":"10.1016\/j.clcc.2023.09.001_bib0030","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ijrobp.2008.04.043","article-title":"Stereotactic body radiotherapy for primary lung cancer at a dose of 50 Gy total in five fractions to the periphery of the planning target volume calculated using a superposition algorithm","volume":"73","author":"Takeda","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.clcc.2023.09.001_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-020-01573-9","article-title":"On the pitfalls of PTV in lung SBRT using type-B dose engine: An analysis of PTV and worst case scenario concepts for treatment plan optimization","volume":"15","author":"Leung","year":"2020","journal-title":"Radiation Oncol"},{"issue":"1059","key":"10.1016\/j.clcc.2023.09.001_bib0032","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20150963","article-title":"The significance of PTV dose coverage on cancer control outcomes in early stage non-small cell lung cancer patients treated with highly ablative stereotactic body radiation therapy","volume":"89","author":"Shaverdian","year":"2016","journal-title":"Br J Radiol"},{"key":"10.1016\/j.clcc.2023.09.001_bib0033","unstructured":"ECOG-ACRIN Cancer Research Group ECOG Performance Status Scale. Accessed January 11, 2022. https:\/\/ecog-acrin.org\/resources\/ecog-performance-status\/."},{"issue":"2","key":"10.1016\/j.clcc.2023.09.001_bib0034","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1245\/s10434-012-2726-3","article-title":"Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review and meta-analysis","volume":"20","author":"Gonzalez","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.clcc.2023.09.001_bib0035","doi-asserted-by":"crossref","DOI":"10.2144\/fsoa-2019-0120","article-title":"Surgery versus stereotactic radiotherapy for treatment of pulmonary metastases. A systematic review of literature","volume":"6","author":"Londero","year":"2020","journal-title":"Future Sci OA"},{"issue":"3","key":"10.1016\/j.clcc.2023.09.001_bib0036","first-page":"188","article-title":"Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases","volume":"12","author":"Brandi","year":"2013","journal-title":"Clin Colorectal Cancer"},{"issue":"2","key":"10.1016\/j.clcc.2023.09.001_bib0037","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.radonc.2017.01.013","article-title":"Stereotactic body radiotherapy for oligo-metastatic liver disease - influence of pre-treatment chemotherapy and histology on local tumor control","volume":"123","author":"Klement","year":"2017","journal-title":"Radiother Oncol"},{"issue":"12","key":"10.1016\/j.clcc.2023.09.001_bib0038","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1038\/sj.bjc.6601418","article-title":"Accelerated regrowth of non-small-cell lung tumours after induction chemotherapy","volume":"89","author":"el Sharouni","year":"2003","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.clcc.2023.09.001_bib0039","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10585-017-9870-x","article-title":"Chemotherapy-induced metastasis: mechanisms and translational opportunities","volume":"35","author":"Karagiannis","year":"2018","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.clcc.2023.09.001_bib0040","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.3389\/fonc.2020.01165","article-title":"Advances in radiobiology of stereotactic ablative radiotherapy","volume":"10","author":"Qiu","year":"2020","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.clcc.2023.09.001_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-019-3837-y","article-title":"Pulmonary metastasectomy versus continued active monitoring in colorectal cancer (PulMiCC): a multicentre randomised clinical trial","volume":"20","author":"Treasure","year":"2019","journal-title":"Trials"},{"issue":"2","key":"10.1016\/j.clcc.2023.09.001_bib0042","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.lungcan.2015.07.009","article-title":"The patient's perspective on stereotactic body radiation therapy (SBRT) vs. surgery for treatment of early stage non-small cell lung cancer (NSCLC)","volume":"90","author":"Shaverdian","year":"2015","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.clcc.2023.09.001_bib0043","doi-asserted-by":"crossref","first-page":"532","DOI":"10.4103\/ijc.IJC_406_19","article-title":"A survey of the practice of stereotactic body radiotherapy for hepatocellular and pancreatic malignancies in India","volume":"58","author":"Lewis","year":"2021","journal-title":"Indian J Cancer"},{"issue":"16","key":"10.1016\/j.clcc.2023.09.001_bib0044","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13164236","article-title":"Prospective evaluation of radiotherapy-induced immunologic and genetic effects in colorectal cancer oligo-metastatic patients with lung-limited disease: the PRELUDE-1 study","volume":"13","author":"Ottaiano","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"25","key":"10.1016\/j.clcc.2023.09.001_bib0045","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial","volume":"38","author":"Palma","year":"2020","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clcc.2023.09.001_bib0046","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1478-4505-13-8","article-title":"Barriers and opportunities for enhancing patient recruitment and retention in clinical research: findings from an interview study in an NHS academic health science centre","volume":"13","author":"Adams","year":"2015","journal-title":"Health Res Policy Syst"},{"issue":"4","key":"10.1016\/j.clcc.2023.09.001_bib0047","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10585-010-9325-0","article-title":"Oligometastases confined one organ from colorectal cancer treated by SBRT","volume":"27","author":"Kang","year":"2010","journal-title":"Clin Exp Metastasis"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002823000865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002823000865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:08:33Z","timestamp":1761520113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002823000865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1533002823000865"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2023.09.001","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stereotactic Body Radiotherapy for Management of Pulmonary Oligometastases in Stage IV Colorectal Cancer: A Perspective","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2023.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}